LaCrosse Virus

NIH investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy

National Institutes of Health investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation.